Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD.

Voorham J, Corradi M, Papi A, Vogelmeier CF, Singh D, Fabbri LM, Kerkhof M, Kocks JH, Carter V, Price D.

ERJ Open Res. 2019 Aug 30;5(3). pii: 00106-2019. doi: 10.1183/23120541.00106-2019. eCollection 2019 Jul.

2.

Needle Placement and Position of Electrical Stimulation Inside Sacral Foramen Determines Pelvic Floor Electromyographic Response-Implications for Sacral Neuromodulation.

Vaganée D, Voorham J, Voorham-van der Zalm P, De Wachter S.

Neuromodulation. 2019 Aug;22(6):709-715. doi: 10.1111/ner.12953. Epub 2019 Apr 30.

PMID:
31039291
3.

Repeatability of tools to assist in the follow up and troubleshooting of sacral neuromodulation patients using the sensory response.

Vaganée D, Van de Borne S, Fransen E, Voorham J, Voorham-van der Zalm P, De Wachter S.

Neurourol Urodyn. 2019 Feb;38(2):801-808. doi: 10.1002/nau.23925. Epub 2019 Jan 15.

PMID:
30644573
4.

Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK.

Voorham J, Roche N, Benhaddi H, van der Tol M, Carter V, van Boven JFM, Bjermer L, Miravitlles M, Price DB.

BMJ Open. 2018 Oct 27;8(10):e022051. doi: 10.1136/bmjopen-2018-022051. Erratum in: BMJ Open. 2018 Dec 9;8(12):e022051corr1. BMJ Open. 2019 Jun 14;9(6):e022051corr2.

5.

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study.

Price DB, Trudo F, Voorham J, Xu X, Kerkhof M, Ling Zhi Jie J, Tran TN.

J Asthma Allergy. 2018 Aug 29;11:193-204. doi: 10.2147/JAA.S176026. eCollection 2018.

6.

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma.

Voorham J, Xu X, Price DB, Golam S, Davis J, Zhi Jie Ling J, Kerkhof M, Ow M, Tran TN.

Allergy. 2019 Feb;74(2):273-283. doi: 10.1111/all.13556. Epub 2018 Nov 20.

7.

Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study.

Voorham J, Vrijens B, van Boven JF, Ryan D, Miravitlles M, Law LM, Price DB.

Pragmat Obs Res. 2017 Apr 18;8:31-41. doi: 10.2147/POR.S132658. eCollection 2017.

8.

Development and validation of prescribing quality indicators for patients with type 2 diabetes.

Smits KP, Sidorenkov G, Kleefstra N, Bouma M, Meulepas M, Voorham J, Navis G, Bilo HJ, Denig P.

Int J Clin Pract. 2017 Jan;71(1). doi: 10.1111/ijcp.12922. Epub 2016 Dec 16.

PMID:
27981681
9.

The effect of EMG biofeedback assisted pelvic floor muscle therapy on symptoms of the overactive bladder syndrome in women: A randomized controlled trial.

Voorham JC, De Wachter S, Van den Bos TWL, Putter H, Lycklama À Nijeholt GA, Voorham-van der Zalm PJ.

Neurourol Urodyn. 2017 Sep;36(7):1796-1803. doi: 10.1002/nau.23180. Epub 2016 Nov 21.

PMID:
27869312
10.

Development and initial validation of prescribing quality indicators for patients with chronic kidney disease.

Smits KP, Sidorenkov G, Bilo HJ, Bouma M, van Ittersum FJ, Voorham J, Navis G, Denig P.

Nephrol Dial Transplant. 2016 Nov;31(11):1876-1886. Epub 2016 Jan 6.

PMID:
26743176
11.

Using primary care electronic health record data for comparative effectiveness research: experience of data quality assessment and preprocessing in The Netherlands.

Huang Y, Voorham J, Haaijer-Ruskamp FM.

J Comp Eff Res. 2016 Jul;5(4):345-54. doi: 10.2217/cer-2015-0022. Epub 2016 Jun 27.

PMID:
27346480
12.

Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: a descriptive study.

de Vries FM, Voorham J, Hak E, Denig P.

Int J Clin Pract. 2016 Jun;70(6):482-92. doi: 10.1111/ijcp.12806. Epub 2016 Apr 29.

PMID:
27125890
13.

Comparing the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on renal function decline in diabetes.

Huang Y, Haaijer-Ruskamp FM, Voorham J.

J Comp Eff Res. 2016 May;5(3):229-37. doi: 10.2217/cer.15.64. Epub 2016 Apr 22.

PMID:
27102734
14.

Identification of major cardiovascular events in patients with diabetes using primary care data.

Pouwels KB, Voorham J, Hak E, Denig P.

BMC Health Serv Res. 2016 Apr 2;16:110. doi: 10.1186/s12913-016-1361-2.

15.

Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients.

de Vries FM, Voorham J, Hak E, Denig P.

Curr Med Res Opin. 2015 Dec;31(12):2197-206. doi: 10.1185/03007995.2015.1092126. Epub 2015 Oct 19.

PMID:
26359331
16.

Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial.

Denig P, Schuling J, Haaijer-Ruskamp F, Voorham J.

BMJ. 2014 Sep 25;349:g5651. doi: 10.1136/bmj.g5651.

17.

Potential overtreatment and undertreatment of diabetes in different patient age groups in primary care after the introduction of performance measures.

de Vries ST, Voorham J, Haaijer-Ruskamp FM, Denig P.

Diabetes Care. 2014;37(5):1312-20. doi: 10.2337/dc13-1861. Epub 2014 Mar 4.

PMID:
24595634
18.

Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes.

de Vries ST, Keers JC, Visser R, de Zeeuw D, Haaijer-Ruskamp FM, Voorham J, Denig P.

J Psychosom Res. 2014 Feb;76(2):134-8. doi: 10.1016/j.jpsychores.2013.11.003. Epub 2013 Nov 13.

19.

Do treatment quality indicators predict cardiovascular outcomes in patients with diabetes?

Sidorenkov G, Voorham J, de Zeeuw D, Haaijer-Ruskamp FM, Denig P.

PLoS One. 2013 Oct 30;8(10):e78821. doi: 10.1371/journal.pone.0078821. eCollection 2013.

20.

Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT database.

Sidorenkov G, Voorham J, de Zeeuw D, Haaijer-Ruskamp FM, Denig P.

BMJ Qual Saf. 2013 Apr;22(4):339-47. doi: 10.1136/bmjqs-2012-001203. Epub 2013 Feb 5.

PMID:
23386729
21.

Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort.

Hellemons ME, Denig P, de Zeeuw D, Voorham J, Lambers Heerspink HJ.

Nephrol Dial Transplant. 2013 Mar;28(3):706-15. doi: 10.1093/ndt/gfs567. Epub 2012 Dec 21.

PMID:
23262433
22.

Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohort.

Sidorenkov G, Voorham J, Haaijer-Ruskamp FM, de Zeeuw D, Denig P.

Med Care. 2013 Feb;51(2):172-9. doi: 10.1097/MLR.0b013e318277eaf5.

PMID:
23222526
23.
24.

Reliability and differentiation of pelvic floor muscle electromyography measurements in healthy volunteers using a new device: the Multiple Array Probe Leiden (MAPLe).

Voorham-van der Zalm PJ, Voorham JC, van den Bos TW, Ouwerkerk TJ, Putter H, Wasser MN, Webb A, DeRuiter MC, Pelger RC.

Neurourol Urodyn. 2013 Apr;32(4):341-8. doi: 10.1002/nau.22311. Epub 2012 Sep 12.

PMID:
22972554
25.

Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort study.

Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, de Zeeuw D, Stolk RP, Denig P.

PLoS One. 2012;7(6):e38707. doi: 10.1371/journal.pone.0038707. Epub 2012 Jun 5.

26.

Medication adherence affects treatment modifications in patients with type 2 diabetes.

Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, Stolk RP, Denig P; Groningen Initiative to Analyze Type 2 Diabetes Treatment Group.

Clin Ther. 2011 Jan;33(1):121-34. doi: 10.1016/j.clinthera.2011.01.024.

27.

Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study.

Voorham J, Haaijer-Ruskamp FM, van der Meer K, de Zeeuw D, Wolffenbuttel BH, Hoogenberg K, Denig P; GIANTT-Group.

Pharmacoepidemiol Drug Saf. 2010 Oct;19(10):1078-86. doi: 10.1002/pds.2023.

PMID:
20687048
28.

Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burden.

Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, Stolk RP, Denig P; Groningen Initiative to Analyse Type 2 Diabetes Treatment Group.

Qual Saf Health Care. 2010 Oct;19(5):411-5. doi: 10.1136/qshc.2008.030106. Epub 2010 Apr 27.

PMID:
20427303
29.

[Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007].

Voorham J, Haaijer-Ruskamp FM, van der Meer K, de Zeeuw D, Wolffenbuttel BH, Hoogenberg K, Denig P.

Ned Tijdschr Geneeskd. 2010;154:A775. Dutch.

PMID:
20132579
30.

A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management.

Martirosyan L, Voorham J, Haaijer-Ruskamp FM, Braspenning J, Wolffenbuttel BH, Denig P.

Pharmacoepidemiol Drug Saf. 2010 Apr;19(4):319-34. doi: 10.1002/pds.1894. Review.

PMID:
19960483
31.

Cross-sectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes.

Voorham J, Denig P, Wolffenbuttel BH, Haaijer-Ruskamp FM.

Med Care. 2008 Feb;46(2):133-41. doi: 10.1097/MLR.0b013e31815b9da0.

PMID:
18219241
32.

Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes.

Voorham J, Haaijer-Ruskamp FM, Stolk RP, Wolffenbuttel BH, Denig P; Groningen Initiative to Analyze Type 2 Diabetes Treatment Group.

Diabetes Care. 2008 Mar;31(3):501-3. Epub 2007 Dec 10.

PMID:
18070994
33.
35.

Use of insecticide-impregnated mosquito nets and other impregnated materials for malaria control in the Americas.

Zimmerman RH, Voorham J.

Rev Panam Salud Publica. 1997 Jul;2(1):18-25. Review.

PMID:
9309945
37.

Reappearance of Plasmodium malariae in Suriname?

Voorham J, van Os N, van der Kaay HJ.

Trans R Soc Trop Med Hyg. 1993 May-Jun;87(3):243-4.

PMID:
8236378
38.

Efficacy of mosquito nets treated with permethrin in Suriname.

Rozendaal JA, Voorham J, Van Hoof JP, Oostburg BF.

Med Vet Entomol. 1989 Oct;3(4):353-65.

PMID:
2519685
39.

Behavioral responses of Anopheles darlingi in Suriname to DDT residues on house walls.

Rozendaal JA, Van Hoof JP, Voorham J, Oostburg BF.

J Am Mosq Control Assoc. 1989 Sep;5(3):339-50.

PMID:
2584967

Supplemental Content

Loading ...
Support Center